• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-(正烷基)-1H-咪唑和4-(ω-苯烷基)-1H-咪唑的合成及组胺H3受体活性

Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.

作者信息

De Esch I J, Gaffar A, Menge W M, Timmerman H

机构信息

Leiden/Amsterdam Center for Drug Research, Department of Pharmacochemistry, Faculty of Chemistry, Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Bioorg Med Chem. 1999 Dec;7(12):3003-9. doi: 10.1016/s0968-0896(99)00253-9.

DOI:10.1016/s0968-0896(99)00253-9
PMID:10658607
Abstract

The influence of lipophilic moieties attached to a 4-1H-imidazole ring on the histamine H3 receptor activity was systematically investigated. Series of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles were prepared, with an alkyl chain varying from 2-9 methylene groups and from 1-9 methylene groups, respectively. The compounds were tested for their activity on the H3 receptor under in vitro conditions. For the 4-(n-alkyl)-1H-imidazoles the activity is proportional to chain length, ranging from a pA2 value of 6.3 +/- 0.2 for 4-(n-propyl)-1H-imidazole to a pA2 value of 7.2 +/- 0.1 for 4-(n-decyl)-1H-imidazole. For the series 4-(omega-phenylalkyl)-4H-imidazoles an optimum in H3 activity was found for the pentylene spacer: 4-(omega-phenylpentyl)-1H-imidazole has a pA2 value of 7.8 +/- 0.1.

摘要

系统研究了连接在4-1H-咪唑环上的亲脂性部分对组胺H3受体活性的影响。制备了一系列4-(正烷基)-1H-咪唑和4-(ω-苯烷基)-1H-咪唑,烷基链分别含有2至9个亚甲基和1至9个亚甲基。在体外条件下测试了这些化合物对H3受体的活性。对于4-(正烷基)-1H-咪唑,活性与链长成比例,4-(正丙基)-1H-咪唑的pA2值为6.3±0.2,4-(正癸基)-1H-咪唑的pA2值为7.2±0.1。对于4-(ω-苯烷基)-4H-咪唑系列,发现戊烯间隔基的H3活性最佳:4-(ω-苯戊基)-1H-咪唑的pA2值为7.8±0.1。

相似文献

1
Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.4-(正烷基)-1H-咪唑和4-(ω-苯烷基)-1H-咪唑的合成及组胺H3受体活性
Bioorg Med Chem. 1999 Dec;7(12):3003-9. doi: 10.1016/s0968-0896(99)00253-9.
2
Homologs of histamine as histamine H3 receptor antagonists: a new potent and selective H3 antagonist, 4(5)-(5-aminopentyl)-1H-imidazole.
J Med Chem. 1995 Jan 20;38(2):266-71. doi: 10.1021/jm00002a008.
3
Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.FUB 181的研发,一种具有4-(ω-(芳基烷氧基)烷基)-1H-咪唑结构的高口服体内活性的选择性组胺H3受体拮抗剂。
Arch Pharm (Weinheim). 1998 Jun;331(6):211-8. doi: 10.1002/(sici)1521-4184(199806)331:6<211::aid-ardp211>3.0.co;2-p.
4
Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities.
Farmaco. 1999 Oct 30;54(10):684-94. doi: 10.1016/s0014-827x(99)00081-6.
5
4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.作为组胺H(3)受体拮抗剂/激动剂的4-(ω-(烷氧基)烷基)-1H-咪唑衍生物
J Med Chem. 2004 May 6;47(10):2678-87. doi: 10.1021/jm031065q.
6
4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.4-[(1H-咪唑-4-基)甲基]苯甲脒和苄脒:组胺H3受体的新型拮抗剂。
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2263-8. doi: 10.1016/s0960-894x(98)00399-0.
7
Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.具有羰基取代的4-(3-(苯氧基)丙基)-1H-咪唑结构的新型组胺H(3)受体拮抗剂,如西普西兰及相关化合物。
J Med Chem. 2000 Oct 19;43(21):3987-94. doi: 10.1021/jm000966l.
8
Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists.新型 1-取代甲基-4-[5-(N-甲基-N-丙基氨基)戊氧基]哌啶和选定的 1-[(N-取代-N-甲基)-3-丙氧基]-5-(N-甲基-N-丙基)-戊二胺作为 H3 拮抗剂的构效关系。
Chem Biol Drug Des. 2014 Jan;83(1):106-18. doi: 10.1111/cbdd.12206. Epub 2013 Oct 28.
9
omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
Bioorg Med Chem. 2002 Feb;10(2):425-32. doi: 10.1016/s0968-0896(01)00295-4.
10
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.组胺H3受体拮抗剂的4-[(1H-咪唑-4-基)甲基]哌啶系列中CYP450抑制作用的降低
Bioorg Med Chem Lett. 2006 Feb 15;16(4):989-94. doi: 10.1016/j.bmcl.2005.10.087. Epub 2005 Nov 15.

引用本文的文献

1
Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.新型二价试剂作为褪黑素和组胺H3配体的合成与表征
Int J Mol Sci. 2014 Sep 12;15(9):16114-33. doi: 10.3390/ijms150916114.
2
SLATE: a method for the superposition of flexible ligands.SLATE:一种柔性配体叠加方法。
J Comput Aided Mol Des. 2001 Jan;15(1):81-96. doi: 10.1023/a:1011102129244.